Akebia Therapeutics
AKBA
AKBA
89 hedge funds and large institutions have $191M invested in Akebia Therapeutics in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 31 reducing their positions, and 14 closing their positions.
Holders
89
Holders Change
-5
Holders Change %
-5.32%
% of All Funds
2.22%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
28
Reduced
31
Closed
14
Calls
$933K
Puts
$322K
Net Calls
+$611K
Net Calls Change
+$197K
Top Buyers
| 1 |
1
BlackRock
New York
|
$24.7M |
| 2 |
NHAS
2
Novo Holdings A/S
Hellerup,
Denmark
|
$11.7M |
| 3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$2.73M |
| 4 |
4
Renaissance Technologies
New York
|
$3.55M |
| 5 |
5
Millennium Management
New York
|
$3.96M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WA
101
WFG Advisors
Dallas,
Texas
| – | – | -100 | Closed |
|
|
HT
102
HAP Trading
New York
| – | – | – | – |
|
|
IA
103
IFP Advisors
Tampa,
Florida
| $0 | 28 | – | – |
|
104
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $0 | 31 | +31 | New |
|